The abnormal expression of B7-H1, B7-H3 and B7-H4 in tumor tissues and tumor microenvironment, as well as the negative regulation of tumor immune response, suggest that these three molecules not only have hidden theoretical research for tumor immunotherapy, it also has potential clinical application value and trans-epochal significance. This evidence concerns the gene CD276 and neoplasm.